November 15, 2022 Pharma | BioTech GTN Summit As a bronze sponsor of the 2022 Informa Connect GTN Summit conference, hosted in Philadelphia November 15-17, 2022, IntegriChain’s pharmaceutical GTN consultants participated in four sessions. Jen SharpeVice President, Gross-To-Net Consulting Session: Revenue Analytics Collaborative (RAC) Group Meeting Biotech and pharma industry participants involved in Government, Commercial, GTN and Trade/Channel Members participated in round table discussions. For more collaboration, visit the Revenue Analytics Collaborative. Jeff BaabVice President, Operational Consulting Session: Changing Policy and Drug Pricing Proposals – Critical Update Jeff Baab provided a real time update on political proposals, legislative items and scenario modeling, including the drug pricing reform impacts as part of the Inflation Reduction Act. Jen SharpeVice President, Gross-To-Net Consulting Session: Corner Office Fireside Chat -GTN’s Importance and Materiality in the Broader Business Equation Jen Sharpe and Mark Glickman, CEO of TherapeuticsMD discussed the role of GTN accuracy and proficiency to the broader business. Corne SmalManager, Gross-To-Net, Managed Services Session: Commercial Planning and New Launch Readiness Corne Smal moderated a panel of industry practitioners including Sandoz (Novartis), Cormedix and Ironshore Pharmaceuticals, discussing best practices leading up to any launch, plus post launch analysis and adjustments. learn more about pharma gtn
